August 3, 2023Open Access

Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non–Small Cell Lung Cancer

Key points are not available for this paper at this time.

ClinicalTrials.gov Identifier: NCT04338620.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Lei et al. (Thu,) studied this question.

Jie Lei

Jinbo Zhao

Li Gong

JAMA Oncology

Lanzhou University

Air Force Medical University

Lanzhou University Second Hospital

Building similarity graph...

Analyzing shared references across papers